A detailed history of Greenfield Savings Bank transactions in Eli Lilly & CO stock. As of the latest transaction made, Greenfield Savings Bank holds 840 shares of LLY stock, worth $668,362. This represents 0.35% of its overall portfolio holdings.

Number of Shares
840
Previous 840 -0.0%
Holding current value
$668,362
Previous $760,000 2.11%
% of portfolio
0.35%
Previous 0.39%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 10, 2024

BUY
$724.87 - $909.04 $3,624 - $4,545
5 Added 0.6%
840 $760,000
Q4 2023

Jan 05, 2024

SELL
$525.19 - $619.13 $5,251 - $6,191
-10 Reduced 1.18%
835 $486,000
Q3 2023

Oct 10, 2023

BUY
$434.7 - $599.3 $367,321 - $506,408
845 New
845 $453,000
Q4 2022

Jan 12, 2023

SELL
$321.55 - $374.67 $8,038 - $9,366
-25 Reduced 3.43%
704 $0
Q2 2022

Jul 29, 2022

BUY
$278.73 - $327.27 $203,194 - $238,579
729 New
729 $236,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Greenfield Savings Bank Portfolio

Follow Greenfield Savings Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Greenfield Savings Bank, based on Form 13F filings with the SEC.

News

Stay updated on Greenfield Savings Bank with notifications on news.